Low-dose aspirin promotes endothelial progenitor cell migration and adhesion and prevents senescence

Cell Biology International

Volumn 32, Issue 7, 2008, Pages 761-768

  Hu, Zhengli ^a   Zhang, Fumin ^a   Yang, Zhijian ^a   Zhang, Jinying ^a   Zhang, Dingguo ^a   Yang, Naiquan ^a   Zhang, Yuqing ^a   Cao, Kejiang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Adhesion; Aspirin; Endothelial progenitor cell; Migration; Proliferation; Senescence

Indexed keywords

ACETYLSALICYLIC ACID; BETA GALACTOSIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN;

ADD ON THERAPY; APOPTOSIS; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LOW DRUG DOSE; PROTEIN EXPRESSION; SENESCENCE; STEM CELL; WESTERN BLOTTING;

APOPTOSIS; ASPIRIN; CELL ADHESION; CELL AGING; CELL MOVEMENT; CELL PROLIFERATION; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; MALE; NITRIC OXIDE SYNTHASE TYPE III; STEM CELLS;

EID: 44449110115     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2008.03.004     Document Type: Article

References (45)

1. Abrams J. Medical therapy of unstable angina and non-Q-wave myocardial infarction. Am J Cardiol 86 suppl (2000) 24J-34J
2. Arango H.A., Icely S., Roberts W.S., Cavanagh D., and Becker J.L. Aspirin effects on endometrial cancer cell growth. Obstet Gynecol 97 (2001) 423-427
3. Assmus B., Urbich C., Aicher A., Hofmann W.K., Haendeler J., Rössig L., et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 92 (2003) 1049-1055
4. Bode-Boger S.M., Martens-Lobenhoffer J., Tager M., Schroder H., and Scalera F. Aspirin reduces endothelial cell senescence. Biochem Biophys Res Commun 334 (2005) 1226-1232
5. Burger P.E., Coetzee S., McKeehan W.L., Kan M., Cook P., Fan Y., et al. Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood 100 (2002) 3527-3535
6. Chen J.Z., Zhu J.H., Wang X.X., Zhu J.H., Xie X.D., Sun J., et al. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol 36 (2004) 233-239
7. Chen T.G., Chen J.Z., and Xie X.D. Effects of aspirin on number, activity and inducible nitric oxide synthase of endothelial progenitor cells from peripheral blood. Acta Pharmacol Sin 27 (2006) 430-436
8. Colleselli D., Bijuklic K., Mosheimer B.A., and Kahler C.M. Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation. Exp Cell Res 312 (2006) 2933-2941
9. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 24 (2003) 1601-1610
10. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92 (1995) 9363-9367
11. Duan H.X., Cheng L.M., Wang J., Hu L.S., and Lu G.X. Angiogenic potential difference between two types of endothelial progenitor cells from human umbilical cord blood. Cell Biol Int 30 (2006) 1018-1027
12. Freimark D., Matetzky S., Leor J., Boyko V., Barbash I.M., Behar S., et al. Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. Am J Cardiol 89 (2002) 381-385
13. Gao J., Niwa K., Sun W., Takemura M., Lian Z., Onogi K., et al. Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci 95 (2004) 901-907
14. Goel A., Chang D.K., Ricciardiello L., Gasche C., and Boland C.R. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin Cancer Res 9 (2003) 383-390
15. Han L., Xu C., Jiang C., Li H., Zhang W., Zhao Y., et al. Effects of polyamines on apoptosis induced by simulated ischemia/reperfusion injury in cultured neonatal rat cardiomyocytes. Cell Biol Int 31 (2007) 1345-1352
16. Hu L., Cheng L., Wang J., Zhao H., Duan H., and Lu G. Effects of human yolk sac endothelial cells on supporting expansion of hematopoietic stem/progenitor cells from cord blood. Cell Biol Int 30 (2006) 879-884
17. Imanishi T., Kobayashi K., Hano T., and Nishio I. Effect of estrogen on differentiation and senescence in endothelial progenitor cells derived from bone marrow in spontaneously hypertensive rats. Hypertens Res 28 (2005) 763-772
18. Juul-Moller S., Edvardsson N., Jahnmatz B., Rosen A., Sorensen S., and Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 340 (1992) 1421-1425
19. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci 97 (2000) 3422-3427
20. Leon M.B., Baim D.S., Popma J.J., Gordon P.C., Cutlip D.E., Ho K.K., et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 339 (1998) 1665-1671
21. Lim H., Fallavollita J.A., Hard R., Kerr C.W., and Canty Jr. J.M. Profound apoptosis-mediated regional myocyte loss and compensatory hypertrophy in pigs with hibernating myocardium. Circulation 100 (1999) 2380-2386
22. Madajka M., Korda M., White J., and Malinski T. Effect of aspirin on constitutive nitric oxide synthase and the bioavailability of NO. Thromb Res 110 (2003) 317-321
23. Mahdi J.G., Mahdi A.J., Mahdi A.J., and Bowen I.D. The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential. Cell Prolif 39 (2006) 147-155
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
25. Nakajima M., Ogawa M., Shimoda Y., Hiraoka S., Iida M., Koseki H., et al. Presenilin-1 controls the growth and differentiation of endothelial progenitor cells through its beta-catenin-binding region. Cell Biol Int 30 (2006) 239-243
26. Olivetti G., Quaini F., Sala R., Lagrasta C., Corradi D., Bonacina E., et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 28 (1996) 2005-2016
27. Pearson T.A., Blair S.N., Daniels S.R., Eckel R.H., Fair J.M., Fortmann S.P., et al. AHA Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106 (2002) 388-391
28. Pitt B., Pepine C., and Willerson J.T. Cyclooxygenase-2 inhibition and cardiovascular events. Circulation 106 (2002) 167-169
29. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9 (2003) 702-712
30. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
31. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
32. Rudic R.D., Shesely E.G., Maeda N., Smithies O., Segal S.S., and Sessa W.C. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101 (1998) 731-736
33. Shiff S.J., Koutsos M.I., Qiao L., and Rigas B. Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res 222 (1996) 179-188
34. Stark L.A., Din F.V., Zwacka R.M., and Dunlop M.G. Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J 15 (2001) 1273-1275
35. Suh W., Kim K.L., Choi J.H., Lee Y.S., Lee J.Y., Kim J.M., et al. C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells. Biochem Biophys Res Commun 321 (2004) 65-71
36. Urbich C., Dernbach E., Zeiher A.M., and Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res 90 (2002) 737-744
37. Vajkoczy P., Blum S., Lamparter M., Mailhammer R., Erber R., Engelhardt B., et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 197 (2003) 1755-1765
38. Van Kerckhoven R., van Veghel R., Saxena P.R., and Schoemaker R.G. Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts. Cardiovasc Res 61 (2004) 620-629
39. Vasa M., Fichtlscherer S., Adler K., Aicher A., Martin H., Zeiher A.M., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
40. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
41. Verheugt F.W. How hot is inflammation in acute coronary syndrome?. Eur Heart J 21 (2000) 1990-1992
42. Verheugt F.W., and Gersh B.J. Aspirin beyond platelet inhibition. Am J Cardiol 90 (2002) 39-41
43. Verma S., Kuliszewski M.A., Li S.H., Szmitko P.E., Zucco L., Wang C.H., et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109 (2004) 2058-2067
44. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
45. Webster K.A. Therapeutic angiogenesis: a complex problem requiring a sophisticated approach. Cardiovasc Toxicol 3 (2003) 283-298